Share price
$4.60
As of Apr 29, 2026
ATRA | NASDAQ
Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc. (ATRA) | runway -0.0 months | financing risk high | market cap $40.3M. Daily snapshot of financials, capital pressure, and recent...
Company websiteLast updated Apr 29, 2026
Market cap
$40.3M
Snapshot valuation
30D volume
68,647 shares
Rolling average daily volume
Runway
-0.0 months
Estimated from precomputed burn and cash
Financing risk
N/A
The company screens as likely to return to the capital markets soon.
Snapshot summary
Runway: -0.0 months based on estimated burn.
Financing signal: The company screens as likely to return to the capital markets soon.
Latest development: Atara Biotherapeutics, Inc. 424B3 2026-03-25.
Recent developments
Atara Biotherapeutics, Inc. 424B3 2026-03-25
424B3 filing submitted on 2026-03-25.
Atara Biotherapeutics, Inc. S-3 2026-03-17
S-3 filing submitted on 2026-03-17.
Atara Biotherapeutics, Inc. 424B5 2026-03-16
424B5 filing submitted on 2026-03-16.
Atara Biotherapeutics, Inc. 10-K 2026-03-16
10-K filed on 2026-03-16.
Atara Biotherapeutics, Inc. 8-K 2026-03-16
8-K filed on 2026-03-16.
Related screens
Low cash runway companies
Companies screening with the shortest estimated runway based on precomputed burn and cash snapshots.
High burn rate companies
Companies with the highest estimated trailing cash burn across the monitored issuer set.
Recent financing disclosures
Companies with recent financing activity, capital raises, or post-balance-sheet funding events.
Pre-market filings
Companies with recent filings or disclosures posted before the market open.
Related companies
Recent documents
Atara Biotherapeutics, Inc. 424B3 2026-03-25
424B3 filing submitted on 2026-03-25.
Mar 24, 2026Open source
Atara Biotherapeutics, Inc. S-3 2026-03-17
S-3 filing submitted on 2026-03-17.
Mar 16, 2026Open source
Atara Biotherapeutics, Inc. 8-K 2026-03-16
8-K filed on 2026-03-16.
Mar 15, 2026Open source
Atara Biotherapeutics, Inc. 10-K 2026-03-16
10-K filed on 2026-03-16.
Mar 15, 2026Open source
Premium analysis
Full filing analysis and proprietary signal detail
Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.
Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures